- Home
- MRK vs PG Comparison
MRK vs PG Comparison
Compare MRK & PG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | PG |
|---|---|---|
| Founded | 2000 | 1837 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.2B | 350.2B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MRK | PG |
|---|---|---|
| Price | $120.72 | $151.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 14 |
| Target Price | $125.59 | ★ $163.64 |
| AVG Volume (30 Days) | ★ 8.6M | 7.3M |
| Earning Date | 04-30-2026 | 04-24-2026 |
| Dividend Yield | ★ 3.06% | 2.89% |
| EPS Growth | 8.01 | ★ 8.14 |
| EPS | N/A | ★ 5.36 |
| Revenue | $65,011,000,000.00 | ★ $84,284,000,000.00 |
| Revenue This Year | $3.61 | $5.76 |
| Revenue Next Year | $5.41 | $2.57 |
| P/E Ratio | ★ N/A | $28.15 |
| Revenue Growth | ★ 1.31 | 0.29 |
| 52 Week Low | $76.66 | $137.62 |
| 52 Week High | $125.14 | $166.90 |
Technical Indicators
Market Signals| Indicator | MRK | PG |
|---|---|---|
| Relative Strength Index (RSI) | 58.90 | 61.16 |
| Support Level | $112.96 | $150.97 |
| Resistance Level | $123.93 | $152.77 |
| Average True Range (ATR) | 2.97 | 2.87 |
| MACD | 0.01 | 0.49 |
| Stochastic Oscillator | 77.21 | 90.79 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About PG Procter & Gamble Company (The)
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate annual global sales of more than $1 billion each, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.